SFAF.org Podcast #52 - HIV meds for HIV prevention? Dr. Bob Grant discusses global PrEP studies.
In this episode, Dr. Bob Grant, Associate Professor of Medicine at UCSF and an investigator at the Gladstone Institute of Virology and Immunology, discusses the PrEP Initiative study. These trials are trying to determine whether HIV medications given to HIV negative people at higher risk of infection will help reduce the amount new infections.
Get the Flash Player to listen to our podcast in your browser.
Dr. Grant will be a speaker at our HIVision forum in San Francisco on Wednesday, April 29th entitled "Is HIV Treatment HIV Prevention?" For more information or to RSVP for this event, visit http://www.sfaf.org/hivision.
Dr. Bob Grant has 26 years of experience with AIDS research and clinical care. He is currently the protocol chair for the PREP Initiative study, a global clinical trial of PrEP among men and MTF transsexual people who also receive standard prevention care. The study is sponsored by the National Institutes of Health with co-funding from the Bill and Melinda Gates Foundation. The study is enrolling in the United States, Peru, Ecuador, Brazil, South Africa, and Thailand.
To listen to our podcast on your computer or mp3 player, download this episode of the SFAF Podcast. If you need podcast help or would like to subscribe to the podcast through iTunes or another program, please visit our podcast help page.
Comments